O6-methylguanine DNA methyltransferase (MGMT) gene promoter methylation and IDH mutation status allow for the stratification into biologically and prognostically distinct subgroups of glioma patients, PsP being more frequent [48]. The gene discussed is MGMT; the disease is glioma.